Eva T. Janson-Tiensuu

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database.

Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database.

Journal: Journal of neuroendocrinology
Published: March 20, 2026

Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms.

Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms.

Journal: Endocrine-related cancer
Published: March 17, 2026

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients.

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients.

Journal: Journal of neuroendocrinology
Published: November 12, 2023

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Journal: Acta oncologica (Stockholm, Sweden)
Published: May 17, 2023

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.

Journal: Journal of neuroendocrinology
Published: February 13, 2023

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort.

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort.

Journal: Endocrine-related cancer
Published: December 14, 2022

Loss of Y in leukocytes as a risk factor for critical COVID-19 in men.

Loss of Y in leukocytes as a risk factor for critical COVID-19 in men.

Journal: Genome medicine
Published: October 05, 2022

A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.

A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.

Journal: Neuroendocrinology
Published: June 03, 2020

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3.

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3.

Journal: PloS one
Published: March 02, 2020

Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors.

Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors.

Journal: Neuroendocrinology
Published: February 27, 2019

Unmet Needs in Appendiceal Neuroendocrine Neoplasms.

Unmet Needs in Appendiceal Neuroendocrine Neoplasms.

Journal: Neuroendocrinology
Published: July 16, 2018

Ghrelin expression is associated with a favorable outcome in male breast cancer.

Ghrelin expression is associated with a favorable outcome in male breast cancer.

Journal: Scientific reports
Published: June 08, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026